Can popular Weight-Loss drugs turn back your Body's clock?

NCT ID NCT07293325

Recruiting now Knowledge-focused Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

Summary

This study is investigating whether two popular weight-loss medications, semaglutide and tirzepatide, can slow down or reverse accelerated aging at the genetic level in adults with obesity. Researchers will give 66 participants one of these drugs or metformin for 24 weeks and measure changes in their 'biological age' using a special DNA test. The goal is to understand if these treatments can counteract the faster aging process often linked to obesity.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULTS WITH SIMPLE OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

The Second Affiliated Hospital, Zhejiang University School of Medicine
RECRUITING

Hangzhou, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ADULTS WITH SIMPLE OBESITY